Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 AUD | -3.23% | -9.09% | -26.83% |
Feb. 22 | PharmX Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 11.95M 7.84M | Sales 2023 | 6.13M 4.02M | Capitalization | 22.1M 14.49M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -1M -656K | EV / Sales 2022 | 1.24 x |
Net cash position 2022 | 5.43M 3.56M | Net cash position 2023 | 12.77M 8.38M | EV / Sales 2023 | 1.52 x |
P/E ratio 2022 |
85.2
x | P/E ratio 2023 |
-20.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.97% |
1 week | -9.09% | ||
Current month | -3.23% | ||
3 months | -16.67% | ||
6 months | -30.23% | ||
Current year | -26.83% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.53% | 414B | |
+15.27% | 242B | |
+20.63% | 104B | |
+17.79% | 83.87B | |
+54.11% | 57.64B | |
+33.59% | 53.37B | |
+6.02% | 37.83B | |
+15.88% | 34.11B | |
-8.32% | 23.18B |
- Stock Market
- Equities
- PHX Stock
- PHX Stock